Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Staphylococcus aureus: Staphylokinase.

Bokarewa MI, Jin T, Tarkowski A.

Int J Biochem Cell Biol. 2006;38(4):504-9. Epub 2005 Aug 2. Review.

PMID:
16111912
2.

Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.

Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A.

J Immunol. 2004 Jan 15;172(2):1169-76.

3.

Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection.

Kwieciński J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, Jin T, Bokarewa M.

J Infect Dis. 2010 Oct 1;202(7):1041-9. doi: 10.1086/656140.

PMID:
20726765
4.

Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing disease severity.

Kwiecinski J, Jacobsson G, Karlsson M, Zhu X, Wang W, Bremell T, Josefsson E, Jin T.

J Infect Dis. 2013 Sep;208(6):990-9. doi: 10.1093/infdis/jit288. Epub 2013 Jun 24.

PMID:
23801604
5.

Interaction of triosephosphate isomerase from Staphylococcus aureus with plasminogen.

Furuya H, Ikeda R.

Microbiol Immunol. 2011 Dec;55(12):855-62. doi: 10.1111/j.1348-0421.2011.00392.x.

6.

Bacteriophage analysis of staphylokinase-negative Staphylococcus aureus strains isolated from people.

Piechowicz L, Galin'ski J, Garbacz K, Haras K.

J Basic Microbiol. 2010 Dec;50(6):557-61. doi: 10.1002/jobm.201000019.

PMID:
20586072
7.

Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.

Mölkänen T, Tyynelä J, Helin J, Kalkkinen N, Kuusela P.

FEBS Lett. 2002 Apr 24;517(1-3):72-8.

8.

Staphylokinase production by clinical Staphylococcus aureus strains.

Wieckowska-Szakiel M, Sadowska B, Rózalska B.

Pol J Microbiol. 2007;56(2):97-102.

PMID:
17650679
9.
10.

The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin.

Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, Eick S, Kellermann J, Schmitt M, Potempa J, Magdolen V.

Biochem J. 2008 Feb 15;410(1):157-65.

PMID:
17973626
11.

Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.

Peetermans M, Vanassche T, Liesenborghs L, Claes J, Vande Velde G, Kwiecinksi J, Jin T, De Geest B, Hoylaerts MF, Lijnen RH, Verhamme P.

BMC Microbiol. 2014 Dec 17;14:310. doi: 10.1186/s12866-014-0310-7.

12.
13.

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel KP, Van Strijp JA, Götz F, Neumeister B, Peschel A.

J Infect Dis. 2002 Jul 15;186(2):214-9. Epub 2002 Jul 3.

PMID:
12134257
14.

Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle.

Monecke S, Kuhnert P, Hotzel H, Slickers P, Ehricht R.

Vet Microbiol. 2007 Nov 15;125(1-2):128-40. Epub 2007 May 24.

PMID:
17614219
15.

Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains.

Jin T, Bokarewa M, McIntyre L, Tarkowski A, Corey GR, Reller LB, Fowler VG Jr.

J Med Microbiol. 2003 Oct;52(Pt 10):919-23.

PMID:
12972589
16.

Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase.

Bokarewa M, Tarkowski A.

Thromb Haemost. 2004 May;91(5):991-9.

PMID:
15116261
17.

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA.

J Exp Med. 2001 May 7;193(9):1067-76.

18.

Anti-opsonic properties of staphylokinase.

Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA.

Microbes Infect. 2005 Mar;7(3):476-84. Epub 2005 Feb 26.

PMID:
15792635
19.

Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation.

Pragman AA, Schlievert PM.

FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):147-54. Review.

20.

Structural consideration of the formation of the activation complex between the staphylokinase-like streptococcal plasminogen activator PadA and bovine plasminogen.

Ward PN, Abu-Median AB, Leigh JA.

J Mol Biol. 2008 Sep 5;381(3):734-47. doi: 10.1016/j.jmb.2008.06.027. Epub 2008 Jun 17.

PMID:
18588895

Supplemental Content

Support Center